Guoxin Securities·2025-11-14 09:49Investment Rating - The investment rating for the organic silicon industry is "Outperform the Market" (maintained) [1][5] Core Viewpoints - The domestic demand for organic silicon continues to grow significantly, while overseas exports have slowed down due to a high base from the previous year. In the first three quarters of 2025, the domestic consumption of organic silicon intermediates reached 1.5128 million tons, a year-on-year increase of 19.66% [3][6] - The peak of capacity expansion has passed, leading to an improved supply structure. The production capacity of organic silicon intermediates in China increased from 1.675 million tons per year in 2020 to 3.44 million tons per year in 2024, with a compound annual growth rate of 19.71% [3][8] - Product prices are at historically low levels and are expected to rise due to coordinated production cuts. As of November 13, 2025, the average price of DMC was 12,500 yuan per ton, up 1,000 yuan from the previous working day [4][13] Summary by Sections Demand Side - Domestic demand for organic silicon intermediates has been consistently high, with a projected apparent consumption of 1.8164 million tons in 2024, reflecting a year-on-year growth of 20.9%. The export volume for organic silicon intermediates in 2024 is expected to recover to 545,700 tons, with a year-on-year growth rate of 34.21% [3][6] Supply Side - The supply side is showing signs of improvement as the peak of capacity expansion has passed. The industry capacity concentration is high, with major players holding significant market shares. As of January 2025, the industry operating rate was 80.69%, which later stabilized around 70% [3][8][9] Price and Profit - The organic silicon industry has faced a significant deterioration in supply-demand dynamics, leading to negative profits. However, with the planned 30% production cut by manufacturers, there is potential for price recovery and positive profit margins in the future [4][13] Investment Recommendations - The report recommends investing in companies such as Xingfa Group, Dongyue Group, and Luxi Chemical, highlighting their competitive advantages and ongoing projects that are expected to enhance their market positions [15][18]